Tirzepatide

Name: Tirzepatide
Availability: tirzepatide-357364.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Tirzepatide
CAS No.:2023788-19-2
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

Ecabet Sodium

Voriconazole(ISO 9001)

Nirmatrelvir

Clindamycin Palmitate Hydrochloride

Piracetam

(5-bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]- Methanone

2-Phenylimidazo[1,2-a]pyridine

benzyl benzoate

Gabapentin

N-([1,1'-biphenyl]-4-yl)-6-(naphthalen-1-yl)-[1,1'-biphenyl]-3-amine

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Dual GIP/GLP-1 agonists gained increasing attention as new therapeutic agents for glycemic and weight control as they demonstrated better glucose control and weight loss compared to selective GLP-1 receptor agonists in preclinical and clinical trials. Tirzepatide was approved by the FDA on May 13, 2022, under the brand name MOUNJARO by the FDA for the treatment of adults with type 2 diabetes, making it the first and only GIP and GLP-1 receptor agonist for this indication.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification: